CA2318236A1 - Composition orale absorbant l'huile - Google Patents

Composition orale absorbant l'huile Download PDF

Info

Publication number
CA2318236A1
CA2318236A1 CA002318236A CA2318236A CA2318236A1 CA 2318236 A1 CA2318236 A1 CA 2318236A1 CA 002318236 A CA002318236 A CA 002318236A CA 2318236 A CA2318236 A CA 2318236A CA 2318236 A1 CA2318236 A1 CA 2318236A1
Authority
CA
Canada
Prior art keywords
oil
sorbing agent
oil sorbing
small
large intestine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002318236A
Other languages
English (en)
Inventor
Stanley Stewart Davis
Peter James Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2318236A1 publication Critical patent/CA2318236A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un système d'administration d'agent absorbant l'huile, qui renferme un agent absorbant l'huile et qui peut administrer ledit agent à l'intestin grêle ou au gros intestin chez un mammifère. L'agent en question peut être un silicate de calcium ou un chitosane microcristallin.
CA002318236A 1998-01-17 1999-01-15 Composition orale absorbant l'huile Abandoned CA2318236A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9800912.9 1998-01-17
GBGB9800912.9A GB9800912D0 (en) 1998-01-17 1998-01-17 New composition
PCT/GB1999/000024 WO1999036075A1 (fr) 1998-01-17 1999-01-15 Composition orale absorbant l'huile

Publications (1)

Publication Number Publication Date
CA2318236A1 true CA2318236A1 (fr) 1999-07-22

Family

ID=10825395

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002318236A Abandoned CA2318236A1 (fr) 1998-01-17 1999-01-15 Composition orale absorbant l'huile

Country Status (9)

Country Link
EP (1) EP1045696A1 (fr)
JP (1) JP2003513000A (fr)
AR (1) AR014422A1 (fr)
AU (1) AU2064399A (fr)
CA (1) CA2318236A1 (fr)
GB (1) GB9800912D0 (fr)
NO (1) NO20003639L (fr)
WO (1) WO1999036075A1 (fr)
ZA (1) ZA99327B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002321707A1 (en) * 2001-08-08 2003-02-24 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
CN1543338B (zh) 2001-08-16 2010-06-16 Cmp医疗有限公司 壳多糖微粒及其医疗用途
FR2838026A1 (fr) * 2003-04-18 2003-10-10 Netlab Dispositif a complement alimentaire
EP2016946B1 (fr) * 2007-07-18 2013-02-27 The Jordanian Pharmaceutical Manufacturing Co. Composition de coprécipité de chitosane et de dioxyde de silicium pour une utilisation en tant qu'agent thérapeutique
CA2895357C (fr) * 2012-12-21 2020-01-07 National Health Research Institutes Nanoparticules de silice mesoporeuse pour l'absorption d'huile
CN103756782B (zh) * 2014-02-12 2015-05-20 中国农业科学院油料作物研究所 一种制取植物油的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
CA2098167C (fr) * 1992-06-24 2006-12-19 Dorothea Isler Aliments pour humains et animaux contenant un inhibiteur de la lipase
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
IT1276617B1 (it) * 1995-11-24 1997-11-03 Ar Trade Invest Sa Preparato dietetico contenente chitosano associato ad altre fibre solubili per il controllo dell'obesita'
FI107432B (fi) * 1997-02-06 2001-08-15 Novasso Oy Mikrokiteisen kitosaanin käyttö
JPH10306028A (ja) * 1997-05-06 1998-11-17 Koji Haraguchi 脂質消化吸収阻害整腸剤

Also Published As

Publication number Publication date
GB9800912D0 (en) 1998-03-11
AU2064399A (en) 1999-08-02
NO20003639L (no) 2000-09-04
WO1999036075A1 (fr) 1999-07-22
AR014422A1 (es) 2001-02-28
JP2003513000A (ja) 2003-04-08
EP1045696A1 (fr) 2000-10-25
NO20003639D0 (no) 2000-07-14
ZA99327B (en) 2000-09-08

Similar Documents

Publication Publication Date Title
Vandamme et al. The use of polysaccharides to target drugs to the colon
Chambin et al. Colon-specific drug delivery: influence of solution reticulation properties upon pectin beads performance
AU667373B2 (en) Compositions of gastric-acid resistant microspheres containing buffered bile acids
JP4088420B2 (ja) 多糖類を利用した大腸選択性薬物伝達組成物および医薬製剤
AU2007233110B2 (en) Polymeric materials as stomach filler and their preparation
TW520292B (en) Drug composition with controlled drug release rate
HU209243B (en) Long acting coated compositions
US20090324537A1 (en) Polymeric Materials as Stomach Filler and Their Preparation
JPH09510478A (ja) 結腸用薬剤分配組成物
AU694849B2 (en) Peroral composition for controlled release in the lower gastrointestinal tract
Kumar et al. Novel colon specific drug delivery system: A review
AU2003274229A1 (en) Galenic formulation for colon targeted delivery of active ingredients
WO2017005888A1 (fr) Formulation comprenant des particules et un inhibiteur de lipase
AU2064399A (en) Oral oil sorbing composition
Ray Advanced colon-specific delivery systems for treating local disorders
JP2670776B2 (ja) ポリマー処理イオン交換樹脂
JP2008513383A (ja) 結腸直腸領域への白金錯体の標的輸送のための経口薬学的組成物、その製造方法及びその薬剤としての使用
JP7499232B2 (ja) 薬剤放出制御剤形
JPH10509982A (ja) 高等植物から獲得できる粉末ヒドロコロイドゴムを利用するｎｓａｉｄの導入
WO2008068762A2 (fr) Formulation de chitosan pour la réduction du cholestérol chez les hommes
JP2000256216A (ja) ゲル組成物
WO2002102415A1 (fr) Systeme flottant gastrique
JPH09241169A (ja) 化合物の放出性及び吸着性を有するゲル状組成物
Milojevic Amylose coated pellets for colon-specific drug delivery
Patel Development and Evaluation of Pulsatile Drug Delivery System of Flurbiprofen

Legal Events

Date Code Title Description
FZDE Dead